Urinary biochemical markers for bone resorption during the menstrual cycle

Area of Science:

• Endocrinology
• Bone Metabolism
• Reproductive Biology

Background:

• Bone metabolism is influenced by hormonal fluctuations.
• The menstrual cycle involves significant changes in ovarian steroid hormones.
• Understanding these hormonal effects on bone is crucial for women's health.

Purpose of the Study:

• To investigate the impact of serum ovarian steroid hormones on bone metabolism markers during the menstrual cycle.
• To analyze the cyclic variations of specific urinary bone resorption markers.
• To correlate these markers with hormonal changes throughout the menstrual cycle.

Main Methods:

• Measurement of urinary bone resorption markers: type I collagen cross-linked N-telopeptide (NTx), hydroxylysylpyridinoline (HP), lysylpyridinoline (LP), and hydroxyproline (OH-Pr).
• Synchronization of menstrual cycles using serum LH peaks and normalization of follicular and luteal periods.
• Analysis of cyclic variations in serum gonadotropins and ovarian sex steroids.

Main Results:

• Urinary NTx levels increased during the mid- and late follicular periods and decreased during the mid- and late luteal periods.
• Significant differences in NTx levels were observed between different phases of the menstrual cycle (P < 0.01 and P < 0.05).
• HP and LP levels rose in the early and mid-follicular periods and fell in the mid-luteal period, with NTx showing a stronger correlation with OH-Pr.

Conclusions:

• Cyclic changes in serum ovarian sex steroids appear to modulate bone resorption markers during the menstrual cycle.
• These findings highlight the dynamic relationship between hormonal fluctuations and bone turnover in women.
• Further research can explore therapeutic interventions targeting these hormonal influences on bone health.